Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients With Systemic Light Chain Amyloidosis

American Journal of Hematology - United States
doi 10.1002/ajh.24723
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders

Case Reports in Medicine
Medicine
2016English

Outcomes of 44 Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion 17p

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease

Haematologica
Hematology
2008English

Cardiac Magnetic Resonance Strain Imaging in Systemic Light Chain Amyloidosis

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2014English

Systemic Light Chain Amyloidosis With Cardiac and Renal Involvements in a Patient With Heart Failure

Cardiology and Cardiovascular Medicine
2017English

Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy

JAMA Cardiology
Cardiovascular MedicineCardiology
2017English

Immunogenetic Characterization of Clonal Plasma Cells in Systemic Light-Chain Amyloidosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis

Journal of Investigative Medicine High Impact Case Reports
RiskEpidemiologyReliabilitySafetySafety ResearchQuality
2019English

A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component in Systemic Light Chain Amyloidosis

Blood Cancer Journal
OncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy